Advanced search
Publication Cover
Leukemia & Lymphoma Volume 60, 2019 - Issue 2
Submit an article Journal homepage
109
Views
1
CrossRef citations to date
0
Altmetric
Letter to the Editor

Acute promyelocytic leukemia in patients aged >70 years is not rare and highly curable: a single center series of 21 unselected patients

Erika BorlenghiASST Spedali Civili di Brescia, UO Ematologia, Brescia, ItalyCorrespondence[email protected]
,
Chiara CattaneoASST Spedali Civili di Brescia, UO Ematologia, Brescia, Italy
,
Francesca SchieppatiASST Spedali Civili di Brescia, UO Ematologia, Brescia, Italy
,
Doriana GramegnaASST Spedali Civili di Brescia, UO Ematologia, Brescia, Italy
,
Angela PassiASST Spedali Civili di Brescia, UO Ematologia, Brescia, Italy
&
Giuseppe RossiASST Spedali Civili di Brescia, UO Ematologia, Brescia, Italy
Pages 531-534 | Received 03 Apr 2018, Accepted 12 Jun 2018, Published online: 30 Aug 2018

References

  • Platzbecker U, Avvisati G, Cicconi L, et al. Improved outcomes with retinoic acid and arsenic trioxide compared with retinoic acid and chemotherapy in non-high-risk acute promyelocytic leukemia: final results of the randomized Italian-German APL0406 Trial. JCO. 2017;35:605–612.
  • Lo-Coco F, Avvisati G, Vignetti M, et al. Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group. Blood. 2010;116:3171–3179.
  • Lengfelder E, Hofmann W-K, Nolte F. Management of elderly patients with acute promyelocytic leukemia: progress and problems. Ann Hematol. 2013;92:1181–1188.
  • Latagliata R, Breccia M, Fazi P, et al. GIMEMA Acute Leukaemia Working Party. GIMEMA AIDA 0493 amended protocol for elderly patients with acute promyelocytic leukemia. Long-term results and prognostic factors. Br J Haematol. 2011;154:564–568.
  • Sanz MA, Vellenga E, Rayon C, et al. All-trans retinoic acid and anthracycline monochemotherapy for the treatment of elderly patients with acute promyelocytic leukemia. Blood. 2004;104:3490–3493.
  • Martınez-Cuadron D, Montesinos P, Vellenga E, et al. Long-term outcome of older patients with newly diagnosed de novo acute promyelocytic leukemia treated with ATRA plus anthracycline-based therapy on behalf of the PETHEMA, HOVON and PALG Groups. Leukemia. 2018;32:21–29.
  • Zhang Y, Zhang Z, Li J, et al. Long-term efficacy and safety of arsenic trioxide for first-line treatment of elderly patients with newly diagnosed acute promyelocytic leukemia. Cancer. 2013;119:115–125.
  • Breccia M, Cimino G, Diverio D, et al. Sustained molecular remission after low dose gemtuzumab ozogamicin in elderly patients with advanced acute promyelocytic leukemia. Haematologica. 2007;92:1273–1274.
  • Sanz MA, Lo Coco F, Martin G, et al. Definition of relapse risk and role of non-anthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Blood. 2000;96:1247–1253.
  • Sanz MA, Grimwade D, Tallman MS, et al. Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood. 2009;113:1875–1891.
  • Disperati P, Minden MD, Gupta V, et al. Acute promyelocytic leukemia in patients aged 70 years and over – a single center experience of unselected patients. Leuk Lymph. 2007;48:1654–1658.
  • Finsinger P, Breccia M, Minotti C, et al. Acute promyelocytic leukemia in patients aged >70 years: the cure beyond the age. Ann Hematol. 2015;94:195–200.
  • Lehmann S, Ravn A, Carlsson L, et al. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry. Leukemia. 2011;25:1128–1134.
  • Lengfelder E, Hanfstein B, Haferlach C, et al. German Acute Myeloid Leukemia Cooperative Group (AMLCG). Outcome of elderly patients with acute promyelocytic leukemia: results of the German acute myeloid leukemia cooperative group. Ann Hematol. 2013;92:41–52.
  • Ferrara F, Finizio O, D’Arco A, et al. Acute promyelocytic leukemia in patients aged over 60 years: multi center experience of 34 consecutive unselected patients. Anticancer Res. 2010;30:967–971.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.